Results in Fig. 2C show that bax/bcl-xl and bax/bcl-2 in myeloid leukemia cells treated by BL–GRh2 is higher than the ratios in the BL group and GRh2-treated cells. This evidence concerns the gene BCL2L1 and myeloid leukemia.